Q3 2025 Sotera Health Co Earnings Call Transcript
Key Points
- Sotera Health Co (SHC) reported strong top-line growth with total company revenues increasing by 9.1% for the quarter.
- The company achieved double-digit adjusted EBITDA growth of 12.2%, with margin expansion of approximately 150 basis points.
- Sotera Health Co (SHC) strengthened its balance sheet by paying down $75 million of debt, reducing annual interest expenses by approximately $13 million.
- Nordion secured a 25-year renewal of its Class 1b operating license, the longest ever granted by the Canadian Nuclear Safety Commission, ensuring a reliable supply of cobalt 60.
- The company reaffirmed its 2025 revenue outlook and raised its adjusted EBITDA outlook, reflecting confidence in its financial performance for the remainder of the year.
- Nelson Labs reported a 5% decline in third-quarter revenue compared to the same period last year, primarily due to a decline in expert advisory services.
- The expert advisory services segment faced headwinds due to a lack of FDA funding and inspections, impacting the top-line performance.
- There is an implied margin step-down expected in the fourth quarter, partially due to the lumpiness in Nordion's volumes.
- The company is facing ongoing litigation related to ethylene oxide emissions, with cases pending in multiple states, including Georgia and California.
- Nelson Labs' full-year 2025 constant currency revenues are expected to decline mid-single digits, as the impact from expert advisory services offsets growth in core lab testing.
Good morning and welcome to the Sotera Health Third quarter 2025 conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0.
After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on a touchtone phone. To withdraw from the question queue, please press star and then 2. Please note this event is being recorded.
I would now like to turn the conference over to Vice President of Investor Relations, Jason Peterson. Jason, please go ahead.
Good morning and thank you. Welcome to Soterra Health 3rd quarter 2025 earnings call. You can find today's press release and accompanying supplemental slides on the investor section of our website at Soterahealth.com.
This webcast is being recorded, and a replay will be available in the investor section of the Satara Health website. On the call with me today are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
